Actively Recruiting
Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
Led by Kocaeli University · Updated on 2024-10-28
80
Participants Needed
2
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Morbid obesity is a growing disease. Intubations of these patients mostly difficult. Video laryngoscopes have to be used during the intubation of these patients. The intubation of men is more complicated and difficult than obese women. There were no trials compared to the new video laryngoscopes in morbidly obese men. Patients will be divided into two groups; non-obese and klas 2-3 obese. Airtraq will be used for their intubation. The time for intubation will be the primary aim of this prospective randomized study. The insertion time, perioperative hemodynamic variables, and postoperative complications will also be recorded.
CONDITIONS
Official Title
Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male aged 18 years or older
- Scheduled for an elective operation requiring intubation
You will not qualify if you...
- Under 18 years old
- Female gender
- Emergency operation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kocaeli University Medical Faculty Hospital
Iamit, Turkey (Türkiye), 41100
Actively Recruiting
2
Kocaeli UniversityMedical Faculty
Kocaeli, Turkey (Türkiye), 41100
Active, Not Recruiting
Research Team
Z
Zehra Arslan, professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
DIAGNOSTIC
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here